GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Common Stock

Rubius Therapeutics (STU:5RT) Common Stock : €0.09 Mil (As of Dec. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics Common Stock?

Rubius Therapeutics's quarterly common stock increased from Jun. 2022 (€0.09 Mil) to Sep. 2022 (€0.09 Mil) but then declined from Sep. 2022 (€0.09 Mil) to Dec. 2022 (€0.09 Mil).

Rubius Therapeutics's annual common stock increased from Dec. 2020 (€0.07 Mil) to Dec. 2021 (€0.08 Mil) and increased from Dec. 2021 (€0.08 Mil) to Dec. 2022 (€0.09 Mil).


Rubius Therapeutics Common Stock Historical Data

The historical data trend for Rubius Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubius Therapeutics Common Stock Chart

Rubius Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
Get a 7-Day Free Trial 0.07 0.07 0.07 0.08 0.09

Rubius Therapeutics Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.08 0.09 0.09 0.09

Rubius Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Rubius Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
124 Washington Street, Suite 101, Foxborough, MA, USA, 02035
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Rubius Therapeutics Headlines

No Headlines